AR013202A1 - NON-WATER VACCINES - Google Patents

NON-WATER VACCINES

Info

Publication number
AR013202A1
AR013202A1 ARP980103379A ARP980103379A AR013202A1 AR 013202 A1 AR013202 A1 AR 013202A1 AR P980103379 A ARP980103379 A AR P980103379A AR P980103379 A ARP980103379 A AR P980103379A AR 013202 A1 AR013202 A1 AR 013202A1
Authority
AR
Argentina
Prior art keywords
methods
immunogenic polypeptide
nonaqueous
vaccine formulation
formulation
Prior art date
Application number
ARP980103379A
Other languages
Spanish (es)
Original Assignee
Biotech Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO7792A external-priority patent/AUPO779297A0/en
Priority claimed from AUPO7791A external-priority patent/AUPO779197A0/en
Application filed by Biotech Australia Pty Ltd filed Critical Biotech Australia Pty Ltd
Publication of AR013202A1 publication Critical patent/AR013202A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Una formulacion de vacuna no acuosa de fase unica que contiene un polipéptido inmunogénico disuelto en un solvente polar no acuoso. Laformulacion también puede contener adjuvantes y/o composiciones farmacéuticas que puedan suministrarse conjuntamente con el polipéptido inmunogénico. Serevelan métodos para preparar dicha formulacion de vacuna y se proporcionan métodos para utilizar las formulaciones a fin de prevenir y tratar enfermedadesde mamíferos.A single phase nonaqueous vaccine formulation containing an immunogenic polypeptide dissolved in a nonaqueous polar solvent. The formulation may also contain adjuvants and / or pharmaceutical compositions that can be supplied together with the immunogenic polypeptide. Methods of preparing such a vaccine formulation are disclosed and methods of using the formulations to prevent and treat mammalian diseases are provided.

ARP980103379A 1997-07-10 1998-07-10 NON-WATER VACCINES AR013202A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO7792A AUPO779297A0 (en) 1997-07-10 1997-07-10 Novel vaccines
AUPO7791A AUPO779197A0 (en) 1997-07-10 1997-07-10 Novel vaccines

Publications (1)

Publication Number Publication Date
AR013202A1 true AR013202A1 (en) 2000-12-13

Family

ID=25645460

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103379A AR013202A1 (en) 1997-07-10 1998-07-10 NON-WATER VACCINES

Country Status (3)

Country Link
AR (1) AR013202A1 (en)
UY (1) UY25089A1 (en)
WO (1) WO1999002182A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27412A1 (en) * 2002-08-12 2003-06-30 Carlson Internat Inc A NEW PRODUCT FOR TICKET FIGHTING AND THE PREPAACINN PROCESS.
JP2013501058A (en) * 2009-08-04 2013-01-10 ジェネンテック， インコーポレイテッド Concentrated polypeptide formulation with reduced viscosity
US9101557B2 (en) 2011-04-13 2015-08-11 Auburn University Combination of protein forms for hornfly vaccination

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711602A (en) * 1970-10-30 1973-01-16 Crown Zellerbach Corp Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso
NZ210505A (en) * 1983-12-22 1988-06-30 Merck & Co Inc Parasiticidal compositions containing avermectin or milbemycin derivatives
US4853372A (en) * 1983-12-22 1989-08-01 Merck & Co., Inc. Non-aqueous ivermectin formulation with improved antiparasitic activity
GB9422990D0 (en) * 1994-11-15 1995-01-04 Cortecs Ltd Immunogenic compositions
SI0750907T1 (en) * 1995-06-30 2002-08-31 American Cyanamid Company Stable macrolide and macrolide vaccine compositions

Also Published As

Publication number Publication date
WO1999002182A3 (en) 1999-04-01
UY25089A1 (en) 2000-08-21
WO1999002182A2 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
AR037490A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS, PROCESS FOR PREPARATION, KIT FOR THE TREATMENT OF OBESITY AND USE OF SUCH COMPOSITIONS IN THE DEVELOPMENT OF MEDICINES
CR7614A (en) INSULIN ACID PREPARATIONS WITH IMPROVED STABILITY
PT758248E (en) FORMULATIONS FOR THE FACTOR IX
ES2174027T3 (en) STABLE COMPOSITIONS CONTAINING MACROLIDES AND MACROLIDES COMBINED WITH VACCINES.
DE69729786D1 (en) HIGHLY CONCENTRATED, LYOPHILIZED AND LIQUID FACTOR IX FORMULATIONS
AR017866A1 (en) METHOD TO INCREASE THE IMMUNORESPUESTAS OF VACCINES OF NUCLEIC ACIDS, PHARMACEUTICAL COMPOSITIONS OF APPLICATION IN SUCH METHOD, PROCEDURE TO PREPARE SUCH COMPOSITIONS AND VACCINES USED IN SUCH METHOD.
MX9306841A (en) UREASE BASED VACCINE AGAINST HELICOBACTER INFECTION IN MAMMALS.
SG156624A1 (en) Organo-gel formulations for therapeutic applications
EA200100425A1 (en) NEW METHODS OF THERAPEUTIC VACCINATION
ES2171923T3 (en) TALIDOMIDE PROFARMS, ITS PREPARATION PROCEDURE AND ITS USE AS ACTIVE PRINCIPLES IN MEDICINES.
ES2160163T3 (en) PHARMACEUTICAL COMPOSITIONS BASED ON DERIVATIVES OF THE CLASS OF TAXANOS.
PT98371A (en) Process for the preparation of ARABINOFURANOSIL-GUANIN 6-ALCOXI DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FI972054A0 (en) Immunogenic compositions
GB2302505A (en) Stabilisation of photosensitive materials
AR013202A1 (en) NON-WATER VACCINES
DK30581A (en) PROCEDURE FOR PREPARING 5-AMINOTETRAZOLD DERIVATIVES OF RETINIC ACIDS
NO992030D0 (en) Therapeutic and cosmetic compositions, their use and methods of preparation thereof
ES2040774T3 (en) PROCEDURE FOR THE PREPARATION OF A DRUG FORMULATION.
NO996074D0 (en) Wax esters enriched in <omega> -3 unsaturated fatty acids, their preparation and their use
ES2178760T3 (en) USE OF SODIUM 2-MERCAPTOETHANOSULPHANATE IN SURGERY.
AP9801399A0 (en) Zona pellucida proteins for contraception.
CA2066945A1 (en) Oral, cutaneous and intravaginal pharmaceutical compositions in the form of foam
CO4750670A1 (en) ANTICICATRIZANTE CREAM BASED CONQUIOLINA
ES2141049A1 (en) Aerosol pharmaceutical formulations which contain medium- chain triglycerides as surfactants.
MX168747B (en) PROCEDURE FOR PREPARING BEAUTY COMPOSITIONS WITH ANTI-PALIDING EFFECT AND THE COMPOSITIONS OBTAINED

Legal Events

Date Code Title Description
FA Abandonment or withdrawal